TIAMATE Drug Patent Profile
✉ Email this page to a colleague
When do Tiamate patents expire, and what generic alternatives are available?
Tiamate is a drug marketed by Merck and is included in one NDA.
The generic ingredient in TIAMATE is diltiazem malate. There are twenty-six drug master file entries for this compound. Additional details are available on the diltiazem malate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for TIAMATE?
- What are the global sales for TIAMATE?
- What is Average Wholesale Price for TIAMATE?
Summary for TIAMATE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 58 |
Patent Applications: | 48 |
Formulation / Manufacturing: | see details |
DailyMed Link: | TIAMATE at DailyMed |
![TIAMATE drug patent expirations Drug patent expirations by year for TIAMATE](/p/graph/s/t/TIAMATE-patent-expirations.png)
US Patents and Regulatory Information for TIAMATE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Merck | TIAMATE | diltiazem malate | TABLET, EXTENDED RELEASE;ORAL | 020506-001 | Oct 4, 1996 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Merck | TIAMATE | diltiazem malate | TABLET, EXTENDED RELEASE;ORAL | 020506-002 | Oct 4, 1996 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Merck | TIAMATE | diltiazem malate | TABLET, EXTENDED RELEASE;ORAL | 020506-003 | Oct 4, 1996 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for TIAMATE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Merck | TIAMATE | diltiazem malate | TABLET, EXTENDED RELEASE;ORAL | 020506-003 | Oct 4, 1996 | ⤷ Sign Up | ⤷ Sign Up |
Merck | TIAMATE | diltiazem malate | TABLET, EXTENDED RELEASE;ORAL | 020506-001 | Oct 4, 1996 | ⤷ Sign Up | ⤷ Sign Up |
Merck | TIAMATE | diltiazem malate | TABLET, EXTENDED RELEASE;ORAL | 020506-002 | Oct 4, 1996 | ⤷ Sign Up | ⤷ Sign Up |
Merck | TIAMATE | diltiazem malate | TABLET, EXTENDED RELEASE;ORAL | 020506-003 | Oct 4, 1996 | ⤷ Sign Up | ⤷ Sign Up |
Merck | TIAMATE | diltiazem malate | TABLET, EXTENDED RELEASE;ORAL | 020506-002 | Oct 4, 1996 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for TIAMATE
See the table below for patents covering TIAMATE around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Ireland | 882899 | ⤷ Sign Up | |
Israel | 87756 | CONTROLLED POROSITY OSMOTIC PUMP | ⤷ Sign Up |
Portugal | 88566 | PROCESSO PARA A PREPARACAO DE UMA BOMBA OSMOTICA DE POROSIDADE CONTROLADA PARA A LIBERTACAO CONTROLADA DE L-MALATO DE DILTIAZEM E BOMBA OSMOTICA ASSIM OBTIDA | ⤷ Sign Up |
Canada | 1320885 | POMPE OSMOTIQUE A POROSITE CONTROLEE (CONTROLLED POROSITY OSMOTIC PUMP) | ⤷ Sign Up |
Greece | 3004364 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |